Top compounds associated with response to AL513412.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA ELCPK CTRPv2 pan-cancer AAC 0.17 0.004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.004
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.004
mRNA MST-312 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.11 0.005
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.11 0.006
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.098 0.006
mRNA rigosertib CTRPv2 pan-cancer AAC 0.1 0.006
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.1 0.007
Download CSV